Br Branebrutinib (BMS-986166)

branebrutinib · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Br Branebrutinib (BMS-986166), covering 2023-10-18 to 2023-10-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis [Phase 2]